Roberto Olivares-Amaya

VP, Multiomics and AI @ LifeMine Therapeutics arrow icon

About Roberto Olivares-Amaya

Roberto Olivares-Amaya is the VP of Multiomics and AI, holding a Ph.D. in chemical physics from Harvard University and a B.Sc. in chemistry from UNAM, with extensive experience in computational chemistry, bioinformatics, and medical informatics.

Known information

Roberto Olivares-Amaya is the Vice President of Multiomics and AI. He holds a Ph.D. in chemical physics from Harvard University and a B.Sc. in chemistry from the National Autonomous University of Mexico (UNAM). He has a rich background in computational chemistry, bioinformatics, and medical informatics, with 10 years of experience at the interface of machine learning and software development for life sciences and healthcare. Roberto began his career at ArcBio, a startup specializing in metagenomics diagnostics, where he created novel methods for genome compression, alignment, variant calling, and pathogen identification. He then served as VP of Technology at GNS Healthcare, leading the development of their causal machine learning platform, REFS. At ConcertAI, he worked as VP of AI Engineering, where he built a team that developed an NLP-based knowledge graph for EHR ontologies. Additionally, he co-founded ‘Clubes de Ciencia Mexico’, an organization dedicated to providing extracurricular STEM education. Roberto also completed a postdoctoral fellowship at Princeton University.

About LifeMine Therapeutics

LifeMine Therapeutics is revolutionizing drug discovery by mining genetically-encoded small molecules from the biosphere, utilizing an advanced AI- and genomically-enabled platform.

report flag Report inaccurate information

People similar to Roberto Olivares-Amaya

Elliot Ehrich

CMO and EVP, Translational Science @ LifeMine Therapeutics

Elliot Ehrich is the CMO and EVP of Translational Science with over 25 years of experience in pharma and biotech, having contributed to the development and registration of 8 medicines across various therapeutic areas.

Lihua Yu is the Chief Data Officer with a Ph.D. in biomedical engineering from Boston University and extensive experience in drug discovery and data science.

Hongyue Dai

VP, Translational Bioinformatics @ LifeMine Therapeutics

Hongyue Dai is the VP of Translational Bioinformatics with over two decades of experience in oncology, immuno-oncology, and neural-immune interactions, known for building and leading bioinformatics teams to support drug discovery and development pipelines.

Unlock exclusive insights

Sign up to reveal more information.

loader Sign up for free